Marrone Bio Gets a Buy Rating from H.C. Wainwright

In a report released today, Amit Dayal from H.C. Wainwright maintained a Buy rating on Marrone Bio (NASDAQ: MBII), with a price target of $3.50. The company’s shares closed yesterday at $1.77.

According to TipRanks.com, Dayal is a 1-star analyst with an average return of 0.0% and a 41.3% success rate. Dayal covers the Consumer Goods sector, focusing on stocks such as Superconductor Technologies Inc, Pacific Ethanol, and Plug Power.

Marrone Bio has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.

See today’s analyst top recommended stocks >>

Based on Marrone Bio’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $2.92 million. In comparison, last year the company had a GAAP net loss of $7.63 million.

Based on the recent corporate insider activity of 10 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Marrone Bio Innovations, Inc. engages in the provision of bio-based pest management and plant health products for the agricultural and water treatment markets. Its brand includes regalia, bio-tam, grandevo, venerate, and majestene. The company was founded by Pamela G. Marrone on June 15, 2006 and is headquartered in Davis, CA.